- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02536677
The Evaluation and Management of Patients With Acute ChesT Pain in China (EMPACT)
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Shandong
-
Jinan, Shandong, China, 250012
- Qilu Hospital of Shandong University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
We used a stratified random sampling design to generate a Shandong province representative sample of hospitals. Twenty two hospitals were randomly selected including 12 rural hospitals, 6 grade II and 4 grade III urban hospitals. One grade II-urban hospital refused to participate. As a coordinating center, Qilu Hospital of Shandong University participated in the study without being sampled. Finally, 22 hospitals were included.
A total of more than 10000 patients were anticipated to be consecutively enrolled from the participating hospitals over the course of the 12-month program. The beginning dates of enrollment in 22 centers were distributed from January, 2016 to September 2016.
Description
Inclusion criteria
- Eighteen years and older
- Presenting to the ED
- With acute chest pain or suspected ACS
- Symptoms occurring within 24 hours
- Informed consent from patient or next of kin
Exclusion criteria
- Chest pain caused by trauma
- Persisting or recurrent chest pain caused by rheumatic diseases or cancer
- Transferred from another grade II or grade III hospital
- Presenting to the ED again within 30 days after initial enrollment
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Major adverse cardiac events (MACE)
Time Frame: 30 days after presenting to the emergency departments(ED)
|
The primary outcome was a composite of adjudicated MACEs, including death from all causes, non-fatal acute myocardial infarction (AMI), urgent revascularization, stroke, cardiac arrest, and cardiogenic shock.
|
30 days after presenting to the emergency departments(ED)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
revisiting to ED and rehospitalization
Time Frame: 30 days after presenting to the EDs
|
30 days after presenting to the EDs
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Yuguo Chen, M.D., Ph.D, Qilu Hospital of Shandong University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- QLEmer201507
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Coronary Syndrome
-
Chulalongkorn UniversityCompletedCKD | Coronary Angiography (CAG) | ACS (Acute Coronary Syndrome)
-
Shenyang Northern HospitalNot yet recruitingSGLT2 Inhibitors | ACS (Acute Coronary Syndrome)China
-
Mahidol UniversityNot yet recruitingCoronary Artery Disease | Acute Coronary Syndrome/ Myocardial InfarctionThailand
-
Aarhus University Hospital SkejbyAbbottEnrolling by invitationIschemic Heart Disease | Ischemic Coronary Artery Disease | ACS (Acute Coronary Syndrome)Denmark, Belgium, Finland, Sweden, Switzerland, Germany, Latvia, Norway, United Kingdom, Estonia, Netherlands, Italy
-
Yonsei UniversityRecruitingCoronary Artery Disease, Acute Coronary SyndromeKorea, Republic of
-
Heart Care FoundationNovartis Farma S.p.A.Not yet recruitingAcute Coronary Syndromes | Chronic Coronary SyndromesItaly
-
University of GalwayNot yet recruitingMyocardial Ischemia | Percutaneous Coronary Intervention | Chronic Coronary Syndrome | Coronary Computed Tomography Angiography | Acute Coronary Syndromes (ACS) | Coronary Arteries Disease
-
Xiling QiRecruitingHF - Heart Failure | ACS (Acute Coronary Syndrome)China
-
Shenyang Northern HospitalChinese Academy of Medical Sciences, Fuwai HospitalNot yet recruitingCoronary Artery Disease (CAD) | Acute Coronary Syndrome (ACS) | High Bleeding Risk(HBR)China
-
SUK MIN SEOBoston Scientific Korea Co. LtdRecruitingAcute Coronary Syndromes (ACS)South Korea